Changes are coming in 2026 for GLP-1 drugs. Long-defined by high prices, shortages and being injectable, drugs including Wegovy and Zepbound may soon be easier to access and afford.

Weight loss pills could mark the most significant shift yet, with a Wegovy pill expected to be widely available this month and another from Eli Lilly expected to gain FDA approval later this year.